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Two genes, bshA and bshB, encoding bile salt hydrolase enzymes (EC 3.5.1.24) were identiﬁed in the genome 
sequence of Lactobacillus acidophilus NCFM. Targeted inactivation of these genes via chromosomal insertion of 
an integration vector demonstrated different substrate speciﬁcities for these two enzymes. 
In humans and other mammals, primary bile salts are pro­
duced de novo in the liver from cholesterol (4). The steroid 
portion of the molecule is conjugated with an amide bond at 
the C-24 position to one of two amino acids, taurine or glycine. 
Following manufacture, conjugated bile salts are stored in the 
gall bladder and secreted via the bile duct into the small in­
testine. Here, these conjugates form spontaneous micelles that 
trap dietary cholesterol and fats, thus facilitating their absorp­
tion by the intestinal epithelium into the bloodstream (25). 
While more than 95% of bile salts enter the enterohepatic 
circulation in humans (17), up to 650 mg of bile salts per day 
elude absorption through the intestinal epithelium. Thus, high 
concentrations of these conjugates are present in the gastro­
intestinal tract. 
Certain species of the indigenous microﬂora, including a 
number of lactobacilli and biﬁdobacteria, have evolved the 
ability to deconjugate bile salts. This action is dependent on 
the presence of an enzyme known as bile salt hydrolase (BSH; 
cholylglycine hydrolase; EC 3.5.1.24) that catalyzes the hydro­
lysis of glycine- and/or taurine-conjugated bile salts into the 
amino acid residue and the bile acid (13). Several theories have 
been proposed for the ecological signiﬁcance of BSH activity in 
these organisms. These include their ability to use free amino 
acids as electron acceptors to obtain energy under anaerobic 
conditions (19, 35) and self-protection against the toxic effects 
of bile salts (32). However, studies on the impact of BSH-
producing organisms in the colonized host have produced 
much conﬂicting evidence. Observations that a reduction in the 
levels of serum cholesterol is associated with the presence of 
BSH-producing organisms has led to increased interest in the 
possibility of their use in hypercholesterolemic individuals or 
to prevent elevated cholesterol levels in individuals with nor­
mal cholesterol status (8). Conversely, negative effects have 
also been reported including cases of contaminated small 
bowel syndrome, impaired lipid absorption, gallstone forma­
tion, and increased risk of colon cancer (25). 
Lactobacillus acidophilus NCFM is a human isolate used 
commercially for over 25 years as a probiotic culture (31). The 
organism has the ability to survive in the gastrointestinal tract 
(31, 33), adhere to human epithelial cells in vitro (16), utilize 
fructooligosaccharides (3), modulate the host immune re­
sponse, and prevent microbial gastroenteritis (36). Analysis of 
the NCFM genome sequence revealed the presence of two 
putative bile salt hydrolase genes (2). The bile-hydrolyzing 
capability associated with L. acidophilus NCFM had been pre­
viously identiﬁed by phenotypic screen (D.C. Walker, unpub­
lished results). Due to the implications of the presence of bile 
salt hydrolase in several probiotic strains, this study was de­
signed to further characterize this activity in NCFM through 
targeted gene inactivation. 
Genomic analysis of the bsh loci. To identify the molecular 
foundations of the relationship between probiotic organisms 
and their hosts, genetic characterization of strains is essential 
(26). Thus, L. acidophilus NCFM was chosen for whole-ge­
nome sequencing. The 2.0-Mb genome sequence of L. aci­
dophilus NCFM has recently been elucidated (2) and contains 
1,864 predicted protein-encoding genes. Sequence analysis was 
performed using a combination of GCG (version 9.1; Univer­
sity of Wisconsin Genetics Computer Group), Clone Manager 
(version 6.0; SciEd Central) and GAMOLA (1). Protein ho­
mology searches were performed with the Basic Local Align­
ment Search Tool (PSI-BLAST), version 2.2, at the website of 
the National Center for Biotechnology Information (http: 
//www.ncbi.nlm.nih.gov). Screening of early drafts of the ge­
nome sequence led to the identiﬁcation of an open reading 
frame (ORF) whose predicted protein sequence showed sig­
niﬁcant similarity to BSH enzymes found in a number of other 
organisms (Table 1). These included Lactobacillus johnsonii 
(82%) (29), Listeria monocytogenes (65%) (9), and Biﬁdobac­
terium longum (54%) (34). This gene was designated bshA. 
Analysis of the genomic organization of the region surround­
ing bshA revealed the presence of a number of ORFs with 
homology to DNA helicases, transporters, and hypothetical 
proteins (Fig. 1). A promoter-type structure and ribosomal 
binding site preceding bshA were identiﬁed, as well as a puta­
tive terminator (lG = -24.7 kcal) downstream, suggesting 
that bshA is transcribed independently of the surrounding 
genes. Subsequent sequencing, leading to improved genome 
assemblies, resulted in the identiﬁcation of another ORF, des­
TABLE 1. Comparison of amino acid sequences of some bacterial BSH enzymes 
BshA BshB 
Bacterial strain/peptide Accession no. 
% Identity % Similarity % Identity % Similarity 
Reference(s)a 
NCFM BshA CP000033 100 100 57 57 2 
L. johnsonii NCC533 (1147) NC_005362 69 82 55 72 29 
Lactobacillus gasseri ADH AAK07837 65 77 56 73 30 
L. gasseri ZP_00046418 65 77 57 73 DS* 
L. johnsonii NCC533 (1412) NC_005362 61 79 57 76 29 
L. johnsonii 100-100 alpha AAG22541 61 79 57 76 10, 11 
Enterococcus faecium FAIR-E 345 AY260046 50 67 57 73 DS* 
L. monocytogenes EGD-e NP_465591 47 65 56 74 9 
E. faecalis V583 NC_004668 49 68 55 73 28 
Lactobacillus plantarum WCFS1 NC_004567 46 65 52 71 23 
L. plantarum 80 Q06115 46 64 52 71 7 
Clostridium perfringens NP_561625 37 56 38 56 5 
B. longum SBT2928 AAF67801 35 54 37 54 34 
L. johnsonii 100-100 beta AAC34381 35 52 33 54 10, 24 
Biﬁdobacterium biﬁdum ATCC11863 AY506536 34 55 37 55 22 
L. acidophilus KS-13 AAD03709 34 51 32 53 DS* 
a *, direct submission to the National Center for Biotechnology Information. 
ignated bshB, the putative gene product of which displayed 
57% identity to that of bshA. Again, a ribosomal binding site 
and putative promoter were identiﬁed within the genome 
structure; a potential terminator (lG = -21.4 kcal) down­
stream also indicates that bshB is most likely to be monocis­
tronic. Genes in the vicinity of bshB were predominantly sim­
ilar to genes encoding hypothetical proteins of unknown 
function (Fig. 1). No other bsh homologues were found in the 
L. acidophilus NCFM genome. The GenBank accession num­
ber for the L. acidophilus NCFM genome sequence from which 
the bshA and bshB genes are derived is CP000033. 
Construction of bsh mutants. The directed integration sys­
tem described previously by Russell and Klaenhammer (30) 
was used to inactivate ﬁrst bshA and then bshB in the genome 
of L. acidophilus NCFM, creating two separate mutants. Prim­
ers were designed to amplify a 588-bp internal region of bshA 
(forward primer, 5'-AAA GTC GAC GAA AAG GGG CTT 
GGT A-3'; reverse primer, 5'-AAG AAT TCC CAT CAG 
GTT GTT CTA C-3'). The underlined restriction sites were 
used to clone the ampliﬁed product into the Ori+ RepA-
integration plasmid, pORI28. The resultant plasmid, 
pTRK734, was transformed into L. acidophilus NCFM con­
taining pTRK669, a temperature-sensitive helper plasmid that 
provides repA in trans for the replication of pORI28. A tem­
perature increase from 37°C to 42°C resulted in the integration 
of pTRK734 into the NCFM genome, concurrent with the loss 
of pTRK669 and its associated Cmr phenotype at the nonper­
missive temperature. To conﬁrm the integration of pTRK734 
at the correct genome locus, Southern hybridizations were 
performed using the 588-bp fragment, labeled with nonradio­
active digoxigenin (DIG) (Roche Diagnostics Corporation, In­
dianapolis, IN), as a probe. The bshA probe hybridized to a 
4.8-kb EcoRI fragment in the wild type (Fig. 2A). In the mu­
tant NCFMlbshA (or NCK1618), this band was absent, and 
due to the presence of a single EcoRI site in the integration 
vector sequence, junction fragments of approximately 4.3 kb 
and 2.7 kb were observed (Fig. 2A). This genome structure is 
indicative of the occurrence of a single crossover homologous 
recombination event (Fig. 2B). An additional band of 2.3 kb 
was detected in the mutant (Fig. 2); this fragment corresponds 
to the integration vector, pTRK734, which had ampliﬁed and 
was present in more than one copy. In the case of bshB, a  
FIG. 1. Schematic representation of the genetic organization of the bsh loci of L. acidophilus NCFM. Arrows indicate ORFs and the directions 
of transcription; bsh genes are represented by solid black arrows. Annotations of ﬂanking genes are also indicated. HP denotes a hypothetical 
protein of unknown function. This representation is not drawn to scale. 
FIG. 2. (A) Southern hybridization analysis of L. acidophilus NCFM and NCK1618. Chromosomal DNA was digested with EcoRI (lanes 1 and 
2) and hybridized with the DIG-labeled 588-bp internal bshA fragment as a probe. Lanes: M, DIG-labeled A-HindIII marker (Roche Molecular 
Biochemicals); 1, NCFM; 2, NCK1618. DNA sizes are indicated in kilobases. (B) Schematic representation of the relevant regions of the NCFM 
and NCFMlbshA (NCK1618) chromosomes. Heavy lines represent chromosomal DNA; thin lines represent plasmid DNA. bshA is represented 
by the arrow, and the shaded box is the internal fragment corresponding to the hybridization probe. EcoRI sites (E) are indicated. 
618-bp internal fragment was ampliﬁed (forward primer, 5'­
AGG ATC CAG TTA GTT CCA TCA GAA TA-3'; reverse 
primer, 5'-TAT AAG CTT GGT ATG GCC GGA CTC AAC­
3') and cloned into pORI28 to create pTRK735 and a similar 
strategy adopted for inactivation. The integration event was 
checked and veriﬁed in a manner similar to that shown in Fig. 
2 for the bshA mutant. The bshB mutant was designated 
NCFMlbshB (or NCK1619). 
Determination of bile tolerance. Bile tolerance is an impor­
tant criterion in the selection of probiotic strains. Previous 
reports have suggested that a concentration of 0.3% oxgall 
(Sigma Chemical Co., St. Louis, MO) closely approximates the 
bile levels found in the gastrointestinal tract (14, 15). To eval­
uate their ability to grow in the presence of bile, the parent, 
NCFMlbshA, and NCFMlbshB were screened for growth on 
MRS plates or in MRS broth supplemented with concentra­
tions of oxgall up to 0.5%. Typically, Lactobacillus spp. do not 
grow at levels higher than 0.3% (20, 21). When incubated 
under anaerobic conditions, the parent was capable of growth 
in up to 0.25% oxgall, as were both NCFMlbshA and 
NCFMlbshB (data not shown). At concentrations of 0.3% and 
higher, no growth was observed for any strain, either in broth 
or on plates. This indicated that inactivation of one or other of 
the bile salt hydrolase enzymes of L. acidophilus NCFM did 
not affect its ability to grow in the presence of bile. 
Detection of BSH activity. A direct plate assay for detection 
of BSH activity was employed to compare the NCFMlbshA 
and NCFMlbshB mutants with the wild-type strain. A number 
of glycine- and taurine-conjugated bile salts were selected for 
the assays; these are listed in Table 2. By the inclusion of bile 
salts in agar medium, BSH-positive strains can be identiﬁed by 
halos of precipitated free bile acids surrounding the colonies 
due to hydrolysis and acidiﬁcation of the medium. The assay 
used in this study is a modiﬁed version of that developed by 
Dashkevicz and Feighner (6); in our assays, the upper concen­
tration of bile salts used was reduced from 0.5% to 0.2% due 
to the inability of L. acidophilus NCFM to grow at 0.5%. In the 
cases of taurochenodeoxycholic acid (TCDCA) and glycoche-
TABLE 2. Analysis of L. acidophilus NCFM and bsh mutants on different bile saltsa 
Value (%) for indicated strain 
Bile salts (%)b NCFM NCFMlbshA NCFMlbshB 
Growth Precipitation Growth Precipitation Growth Precipitation 
TDCA (0.2) 100 100 100 100 100 0 
TCA (0.2) 100 60 100 60 100 0 
TCDCA (0.05) 100 100 100  0 5 0 
TCDCA (0.02) 100 100 100  5 5 0 
GDCA (0.2) 60 60 60 60 60 60 
GCA (0.2) 100 100 100 100 100 100 
GCDCA (0.05) 30 30 30 0 30 30 
GCDCA (0.02) 30 30 30 5 30 30 
a Numeric values represent an arbitrary scoring system; levels of growth and precipitation are scored relative to NCFM on 0.2% TDCA, which is given a score of 
100%. 
b GDCA, glycodeoxycholic acid; GCA, glycocholic acid. 
FIG. 3. Plate assays for the detection of BSH activity. (A) L. acidophilus NCFM; (B) NCFMlbshA (NCK1618); (C) NCFMlbshB (NCK1619) 
on MRS agar containing 0.2% TDCA. In the assays shown, precipitation in the agar is indicative of BSH activity speciﬁc for TDCA. 
nodeoxycholic acid (GCDCA), this concentration was reduced 
further to 0.02 to 0.05%. For the wild-type strain, hydrolysis of 
taurodeoxycholic acid (TDCA) (Table 2 and Fig. 3A) and 
taurocholic acid (TCA) (Table 2) under anaerobic conditions 
resulted in signiﬁcant amounts of deoxycholic acid precipitat­
ing around active colonies. Similar levels of precipitation were 
observed surrounding colonies of NCFMlbshA when plated 
on TDCA (Table 2 and Fig. 3B) and TCA (Table 2), indicating 
that this mutant had retained the ability to hydrolyze these 
deoxy-conjugated compounds. Furthermore, NCFMlbshA re­
tained the ability to hydrolyze the glycine-conjugated com­
pounds such as glycodeoxycholic acid and glycocholic acid. 
Hydrolysis of TCDCA and GCDCA by L. acidophilus NCFM 
was observed as a cloudiness in the agar rather than as distinct 
zones of precipitation observed for the other bile salts. How­
ever, while both the parent and mutant grew, albeit slowly, on 
0.05% TCDCA and GCDCA, NCFMlbshA appeared to have 
lost the ability to hydrolyze both salts (Table 2), as indicated by 
the lack of precipitation in the agar. Interestingly, when both 
TCDCA and GCDCA concentrations in the agar were further 
reduced to 0.02%, NCFMlbshA showed some signs of BSH 
activity (Table 2). The creation of a lbshB mutant allowed the 
activities of BshB to be assessed in a similar manner. Compar­
isons with the parent strain demonstrated that while 
NCFMlbshB displayed growth on and precipitation of all gly­
coconjugates tested, this mutant was capable of growth but 
incapable of precipitation of the tauroconjugated bile salts, 
TCA, TDCA, and TCDCA (Table 2 and Fig. 3C). 
Thus, to summarize, while NCFMlbshA was capable of 
the hydrolysis of some tauro- and glycoconjugated bile salts, 
this mutant had a reduced ability to hydrolyze TCDCA and 
GCDCA, bile salts containing chenodeoxycholic acid as the 
steroid moiety. Conversely, inactivation of bshB revealed that 
the BshB enzyme encoded by this gene appears to exhibit 
substrate speciﬁcity dictated by the amino acid conjugated to 
the bile salt. This conclusion was made based on the inability of 
NCFMlbshB to hydrolyze any bile salt conjugated to taurine. 
Previous studies have demonstrated that the speciﬁcity of the 
catalytic activities of BSH enzymes may be inﬂuenced either by 
To our knowledge, this is the ﬁrst report of the presence of 
two BSH enzymes with different substrate speciﬁcities in a 
single strain of Lactobacillus. Although BSH production is not 
an essential attribute for organisms that colonize the gastroin­
testinal tract, its importance in colonizing species of Lactoba­
cillus is highlighted by the high level of conservation between 
the various enzymes indicated in Table 1. However, after a 
comparison of both predicted protein sequences to the de­
duced amino acid sequences of other BSH enzymes, it was 
interesting that they both share a higher level of identity to 
enzymes from other Lactobacillus species than to each other. 
BshA shares 69% identity with the enzyme from L. johnsonii 
NCC533 (29), while BshB is more similar (57% identity; 76% 
similarity) to that of BSH alpha from L. johnsonii 100-100 (11). 
No such identity was observed at the DNA level. However, the 
G+C contents of both genes are similar to those of other genes 
in the L. acidophilus NCFM genome. Therefore, it is possible 
that bshA and bshB may have originated from different sources 
through horizontal gene transfer from a closely related ge­
nome, but we have no tangible evidence for this at the present 
time. Another possibility is that these genes may have arisen 
from a duplication event, following which the genes have sub­
sequently diverged to encode enzymes with different substrate 
speciﬁcities. However, since the proteins share only 57% iden­
tity, this scenario is unlikely. 
While the evolution of BSH enzymes with different activities 
in L. acidophilus NCFM is striking, the signiﬁcance of BSH 
activity in lactobacilli is still far from understood. Since the free 
bile acids appear to be more inhibitory than the conjugated 
bile salts themselves, it is most likely not a detoxiﬁcation mech­
anism for these organisms. While some positive effects of the 
consumption of BSH-producing probiotics have been docu­
mented, the effects are often transient and unsustainable. Gen­
erally, human studies have yielded mixed results with no clear-
cut reduction in cholesterol observed due to probiotic 
consumption (12). It seems that the debate will continue as to 
whether or not this enzyme activity is a desirable property in 
probiotic bacteria. 
the amino acid in the conjugate or by other side chains in the 
steroid moiety (13, 18, 27). Our results suggest that BshA 
activity is dictated by the steroid nucleus of the conjugated bile 
salt, while the speciﬁcity of BshB is determined by the presence 
of taurine in the bile salt structure. 
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